WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'2701 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 6'5331 Child (under 5 years) mortality rate: 302

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 98'394  96'707  95'053  93'444  91'886  77'652  61'949  47'398 
Births 2'404  2'383  2'362  2'344  2'331  2'301  2'043  1'737 
Surviving infants 2'354  2'332  2'311  2'293  2'280  2'236  1'969  1'634 
Pop. less than 5 years 11'334  11'165  11'097  11'180  11'208  10'682  9'450  7'678 
Pop. less than 15 years 33'593  33'334  33'112  32'970  32'746  29'904  25'359  20'434 
Female 15-49 years 25'337  24'873  24'402  23'909  23'472  19'558  15'026  11'009 

Number of reported case

(Click for retrospective incidence data for Philippines (the))
Diphtheria 107  118  88  921  1'910 
Japanese encephalitis 24  181 
Measles 2'920  1'536  6'538  6'368  1'469  7'120  42'938  26'765 
Mumps
Pertussis 23  62  23  4'135  19'844 
Polio* 85  432 
Rubella 254  100  926  578 
Rubella (CRS)
Tetanus (neonatal) 77  131  166  126  172  281  291  1'506 
Tetanus (total) 1'069  1'537  1'140  1'022  1'135  2'286  3'080 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Philippines (the))
Vaccine year result method % card seen                                                
BCG 2007  94  DHS   43  91  88  84  83  90  81  96  74 
DTP1 2007  93  DHS   43  98  90  85  81  90  81 
DTP3 2007  86  DHS   43  94  86  80  79  87  79  88  47 
HepB_BD          44  35  40  37  34 
HepB3 2007  80  DHS   43  94  70  76  77  85 
Hib3          94  23  14 
JapEnc         
MCV 2007  85  DHS   43  90  85  79  80  88  80  85 
MCV2          53  38  28  10  58 
PCV1         
PCV3         
Pol3 2007  85  DHS   43  88  86  80  78  86  75  88  50 
Rota1          95  46 
Rota_last          97  19 
Rubella1         
TT2plus 2003  37  DHS   39  28  28  38  28  43  58  47 
PAB         
VAD1          85  91  94  91  74 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Philippines (the))
BCG 91  88  84  83  90  92  96  56 
DTP1 98  90  85  81  89  92  96  72 
DTP3 94  86  80  79  87  78  88  47 
HepB3 94  70  76  77  85 
HepB_BD 44  35  40  37  34 
Hib3 94  23  14 
MCV 90  85  79  80  88  78  85 
MCV2 53  38  28  10  19 
PAB 80  76  76  75  68  55  57 
PnC3
Pol3 88  86  80  78  86  74  88  50 
Rota_last 28 

Number of districts in the country 218  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 31
From 80 to 89% 22
From 50 to 79% 28
Less than 50% 6
Proportion of districts
not reporting DTP3 coverage
13
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
IPV 14 weeks; Yes From November 2014
MMR 12-15 months; Yes
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; No
Rotavirus 6-15, 32 weeks; No
TT Yes pregnant women
Td 10-19 years; Yes
VitaminA 6, 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  No  No  Yes  Yes 
What years does the MYP cover? number   2012-2016        2009-2013  2003-2007 
Nº of districts with microplans that include activities to raise immunization coverage number 218  110  217  217  90  90  85 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 218  217  217  217  179  217  213 
Nº districts with DTP3 coverage >=80% number 115  110  103  81  128  146  47 
% of districts with DTP3 coverage >=80% From 0 to 100% 53  51  47  37  72  67  22 
Nº districts with measles (MCV1) coverage >=95% number 40  32  36  28  48  62   
% of districts with MCV1 coverage >=95% From 0 to 100% 18  15  17  13  27  29   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  83  100  171  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.